Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezetimibe plus simvastatin vs high-dose simvastatin in type 2 diabetes with coronary heart disease
2004-002236-26Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hypercholesterolemia, type 2 diabetes mellitus (T2DM) and coronary arteriosclerosis comparing Ezetimibe + simvastatin 20 mg with High-dose simvastatin + placebo (2 arms). Started Aug 2005; status: completed.
02
Drugs
ezetimibesimvastatin
03
Conditions
hypercholesterolemiatype 2 diabetes mellitus (T2DM)coronary arteriosclerosis
Beyond the preview
Go deeper on 2004-002236-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002236-26.